These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 28212569)
1. MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma. Zhao Y; Ling Z; Hao Y; Pang X; Han X; Califano JA; Shan L; Gu X Oncotarget; 2017 Apr; 8(15):25005-25020. PubMed ID: 28212569 [TBL] [Abstract][Full Text] [Related]
2. Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis. Hauser B; Zhao Y; Pang X; Ling Z; Myers E; Wang P; Califano J; Gu X PLoS One; 2015; 10(3):e0116321. PubMed ID: 25764126 [TBL] [Abstract][Full Text] [Related]
3. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438 [TBL] [Abstract][Full Text] [Related]
4. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas. Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569 [TBL] [Abstract][Full Text] [Related]
5. MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC). Zhang J; Wang Y; Chen X; Zhou Y; Jiang F; Chen J; Wang L; Zhang WF Oncotarget; 2015 Apr; 6(10):7454-69. PubMed ID: 25762634 [TBL] [Abstract][Full Text] [Related]
6. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma. Qiu K; Huang Z; Huang Z; He Z; You S Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814 [TBL] [Abstract][Full Text] [Related]
7. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma. Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510 [TBL] [Abstract][Full Text] [Related]
8. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma. Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691 [TBL] [Abstract][Full Text] [Related]
9. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1. Cao XZ; Bin H; Zang ZN Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451 [TBL] [Abstract][Full Text] [Related]
10. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cɛ. Datta J; Smith A; Lang JC; Islam M; Dutt D; Teknos TN; Pan Q Oncogene; 2012 Sep; 31(36):4045-53. PubMed ID: 22158047 [TBL] [Abstract][Full Text] [Related]
11. miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo. Li J; Lei H; Xu Y; Tao ZZ PLoS One; 2015; 10(8):e0135265. PubMed ID: 26258591 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression. Cai Z; Hao XY; Liu FX Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635 [TBL] [Abstract][Full Text] [Related]
13. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270 [TBL] [Abstract][Full Text] [Related]
14. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma. Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898 [TBL] [Abstract][Full Text] [Related]
15. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766 [TBL] [Abstract][Full Text] [Related]
16. SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells. Gong ZH; Ji J; Yao J; Ji JF; Jiang Y; Gao G; Feng Z Aging (Albany NY); 2021 Jan; 13(3):3726-3741. PubMed ID: 33465049 [TBL] [Abstract][Full Text] [Related]
17. miR-204 inhibits angiogenesis and promotes sensitivity to cetuximab in head and neck squamous cell carcinoma cells by blocking JAK2-STAT3 signaling. Wu Q; Zhao Y; Wang P Biomed Pharmacother; 2018 Mar; 99():278-285. PubMed ID: 29353201 [TBL] [Abstract][Full Text] [Related]
18. Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer. Masood R; Roy I; Zu S; Hochstim C; Yong KT; Law WC; Ding H; Sinha UK; Prasad PN Integr Biol (Camb); 2012 Feb; 4(2):132-41. PubMed ID: 22159374 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma. Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319 [TBL] [Abstract][Full Text] [Related]
20. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Kinoshita T; Hanazawa T; Nohata N; Kikkawa N; Enokida H; Yoshino H; Yamasaki T; Hidaka H; Nakagawa M; Okamoto Y; Seki N Oncotarget; 2012 Nov; 3(11):1386-400. PubMed ID: 23159910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]